Skip to main content
SpringerLink
Log in

Alemtuzumab

Thyroid dysfunction and hyperthyroidism: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Shaamile F, et al. Alemtuzumab-Related thyroid dysfunction in patients with relapsing-remitting Multiple Sclerosis. Irish Journal of Medical Science 188 (Suppl. 9): S248 (plus poster) abstr. P130, 2019. Available from: URL: http://doi.org/10.1007/s11845-019-02073-w [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1816, 17 (2020). https://doi.org/10.1007/s40278-020-81652-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-81652-1

Search

Navigation